Analyzing electroCore (NASDAQ:ECOR) & Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL)

electroCore (NASDAQ:ECOR) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation.

Profitability

This table compares electroCore and Pheton Holdings Ltd Class A Ordinary Shares’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
electroCore	-54.40%	-154.45%	-69.16%
Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A

Earnings & Valuation

This table compares electroCore and Pheton Holdings Ltd Class A Ordinary Shares”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$25.18 million	1.91	-$18.83 million	($1.62)	-4.13
Pheton Holdings Ltd Class A Ordinary Shares	$448,196.00	52.72	N/A	N/A	N/A

Pheton Holdings Ltd Class A Ordinary Shares has lower revenue, but higher earnings than electroCore.

Institutional & Insider Ownership

26.7% of electroCore shares are held by institutional investors. 19.7% of electroCore shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for electroCore and Pheton Holdings Ltd Class A Ordinary Shares, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	0	0	2	0	3.00
Pheton Holdings Ltd Class A Ordinary Shares	0	0	0	0	0.00

electroCore currently has a consensus price target of $25.50, suggesting a potential upside of 281.17%. Given electroCore’s stronger consensus rating and higher probable upside, equities research analysts clearly believe electroCore is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.

Summary

electroCore beats Pheton Holdings Ltd Class A Ordinary Shares on 6 of the 10 factors compared between the two stocks.

About electroCore

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.